In the USA, the National Institute of Allergy and Infectious Diseases (NIAID) has awarded $67.5 million to a consortium of researchers working on pandemic preparedness.
As the coronavirus pandemic continues to be felt around the world, the White House and federal agencies in the country are eager to ensure that future pandemic threats are addressed in a more effective way.
The money will be used by scientists at the UC San Francisco (UCSF) Quantitative Biosciences Institute (QBI) and the QBI Coronavirus Research Group (QCRG), and will cover an initial three-year period.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze